Dimensional Fund Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $62M | Buy |
1,292,688
+41,840
| +3% | +$1.8M | 0.01% | 1469 |
|
|
2026
Q1 | $46M | Sell |
1,250,848
-75,210
| -6% | -$3.56M | 0.01% | 1547 |
|
|
2025
Q4 | $67.5M | Sell |
1,326,058
-12,589
| -0.9% | -$644K | 0.01% | 1342 |
|
|
2025
Q3 | $74.3M | Sell |
1,338,647
-135,375
| -9% | -$7.92M | 0.02% | 1283 |
|
|
2025
Q2 | $102M | Sell |
1,474,022
-5,600
| -0.4% | -$381K | 0.02% | 994 |
|
|
2025
Q1 | $103M | Sell |
1,479,622
-4,147
| -0.3% | -$343K | 0.03% | 953 |
|
|
2024
Q4 | $128M | Sell |
1,483,769
-159,635
| -10% | -$17.3M | 0.03% | 826 |
|
|
2024
Q3 | $196M | Buy |
1,643,404
+23,665
| +1% | +$3.16M | 0.05% | 498 |
|
|
2024
Q2 | $231M | Sell |
1,619,739
-128,604
| -7% | -$17M | 0.06% | 373 |
|
|
2024
Q1 | $224M | Sell |
1,748,343
-26,456
| -1% | -$3.15M | 0.06% | 378 |
|
|
2023
Q4 | $184M | Sell |
1,774,799
-3,535
| -0.2% | -$350K | 0.05% | 455 |
|
|
2023
Q3 | $162M | Buy |
1,778,334
+45,188
| +3% | +$3.98M | 0.05% | 450 |
|
|
2023
Q2 | $140M | Buy |
1,733,146
+44,618
| +3% | +$3.64M | 0.04% | 557 |
|
|
2023
Q1 | $134M | Buy |
1,688,528
+9,584
| +0.6% | +$680K | 0.05% | 572 |
|
|
2022
Q4 | $114K | Buy |
1,678,944
+109,744
| +7% | +$6.43M | 0.03% | 687 |
|
|
2022
Q3 | $78.2M | Buy |
1,569,200
+43,958
| +3% | +$2.35M | 0.03% | 882 |
|
|
2022
Q2 | $85M | Buy |
1,525,242
+46,072
| +3% | +$2.56M | 0.03% | 857 |
|
|
2022
Q1 | $82.1M | Buy |
1,479,170
+13,806
| +0.9% | +$709K | 0.03% | 993 |
|
|
2021
Q4 | $82.1M | Buy |
1,465,364
+34,356
| +2% | +$1.86M | 0.02% | 1043 |
|
|
2021
Q3 | $68.7M | Buy |
1,431,008
+950
| +0.1% | +$45.9K | 0.02% | 1146 |
|
|
2021
Q2 | $59.9M | Sell |
1,430,058
-39,072
| -3% | -$1.51M | 0.02% | 1288 |
|
|
2021
Q1 | $49.5M | Sell |
1,469,130
-16,228
| -1% | -$578K | 0.02% | 1450 |
|
|
2020
Q4 | $51.9M | Buy |
1,485,358
+644
| +0% | +$22.3K | 0.02% | 1335 |
|
|
2020
Q3 | $51.5M | Sell |
1,484,714
-8,990
| -0.6% | -$300K | 0.02% | 1177 |
|
|
2020
Q2 | $48.9M | Hold |
1,493,704
| – | – | 0.02% | 1220 |
|
|
2020
Q1 | $45M | Sell |
1,493,704
-1,818
| -0.1% | -$54.1K | 0.02% | 1106 |
|
|
2019
Q4 | $43.3M | Hold |
1,495,522
| – | – | 0.02% | 1552 |
|
|
2019
Q3 | $38.7M | Sell |
1,495,522
-900
| -0.1% | -$22.8K | 0.02% | 1603 |
|
|
2019
Q2 | $38.2M | Buy |
1,496,422
+5,136
| +0.3% | +$127K | 0.01% | 1650 |
|
|
2019
Q1 | $39M | Sell |
1,491,286
-19,610
| -1% | -$482K | 0.02% | 1630 |
|
|
2018
Q4 | $34.8M | Sell |
1,510,896
-102
| -0% | -$2.27K | 0.02% | 1606 |
|
|
2018
Q3 | $35.6M | Buy |
1,510,998
+1,998
| +0.1% | +$48.8K | 0.01% | 1763 |
|
|
2018
Q2 | $34.8M | Hold |
1,509,000
| – | – | 0.01% | 1762 |
|
|
2018
Q1 | $37.2M | Hold |
1,509,000
| – | – | 0.02% | 1651 |
|
|
2017
Q4 | $40.5M | Buy |
1,509,000
+3,492
| +0.2% | +$88.8K | 0.02% | 1571 |
|
|
2017
Q3 | $36.2M | Hold |
1,505,508
| – | – | 0.02% | 1619 |
|
|
2017
Q2 | $32.3M | Sell |
1,505,508
-8,436
| -0.6% | -$170K | 0.01% | 1681 |
|
|
2017
Q1 | $25.9M | Sell |
1,513,944
-2,016
| -0.1% | -$35.1K | 0.01% | 1826 |
|
|
2016
Q4 | $27.2M | Sell |
1,515,960
-12,672
| -0.8% | -$230K | 0.01% | 1741 |
|
|
2016
Q3 | $31.8M | Sell |
1,528,632
-66,606
| -4% | -$1.65M | 0.02% | 1511 |
|
|
2016
Q2 | $42.9M | Buy |
1,595,238
+5,540
| +0.3% | +$152K | 0.02% | 1139 |
|
|
2016
Q1 | $43.1M | Buy |
1,589,698
+793,138
| +100% | +$21.2M | 0.03% | 1100 |
|
|
2015
Q4 | $23.1M | Buy |
796,560
+5,352
| +0.7% | +$148K | 0.01% | 1652 |
|
|
2015
Q3 | $21.5M | Hold |
791,208
| – | – | 0.01% | 1672 |
|
|
2015
Q2 | $21.7M | Hold |
791,208
| – | – | 0.01% | 1776 |
|
|
2015
Q1 | $21.1M | Sell |
791,208
-39,816
| -5% | -$917K | 0.01% | 1742 |
|
|
2014
Q4 | $17.6M | Buy |
831,024
+69,172
| +9% | +$1.55M | 0.01% | 1877 |
|
|
2014
Q3 | $18.1M | Hold |
761,852
| – | – | 0.01% | 1728 |
|
|
2014
Q2 | $17.6M | Buy |
761,852
+83,642
| +12% | +$1.85M | 0.01% | 1774 |
|
|
2014
Q1 | $15.5M | Buy |
678,210
+8,940
| +1% | +$190K | 0.01% | 1819 |
|
|
2013
Q4 | $12.4M | Sell |
669,270
-23,490
| -3% | -$409K | 0.01% | 1998 |
|
|
2013
Q3 | $11.7M | Buy |
692,760
+7,910
| +1% | +$133K | 0.01% | 1971 |
|
|
2013
Q2 | $10.6M | Buy |
+684,850
| New | +$11.4M | 0.01% | 1935 |
|
Other funds holding NVO
F
Dimensional Fund Advisors's NVO Position: Q2 2026 in Review
Dimensional Fund Advisors increased its Novo Nordisk (NVO) stake by 3.3% in Q2 2026, buying an estimated $1.8M and bringing the position to 1,292,688 shares worth $62M. The position accounts for 0.01% of the portfolio, ranked #1469.
Dimensional Fund Advisors first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $231M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Dimensional Fund Advisors held 1,292,688 shares of Novo Nordisk worth $62M as of Q2 2026.
- Dimensional Fund Advisors bought 41,840 Novo Nordisk shares in Q2 2026, an estimated $1.8M.
- Novo Nordisk made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1469 holding.
- Dimensional Fund Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- Dimensional Fund Advisors's Novo Nordisk position peaked at $231M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.